| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 100.20B | 91.17B | 42.35B | 48.60B | 45.54B | 52.41B |
| Gross Profit | 76.57B | 71.36B | 42.35B | 35.76B | 34.72B | 42.25B |
| EBITDA | 44.98B | 58.63B | 0.00 | 13.55B | 15.35B | 20.25B |
| Net Income | 21.75B | 27.09B | 13.02B | 9.37B | 11.51B | 15.01B |
Balance Sheet | ||||||
| Total Assets | 2.26T | 2.12T | 1.05T | 925.40B | 860.69B | 791.27B |
| Cash, Cash Equivalents and Short-Term Investments | 1.67T | 795.85B | 883.49B | 326.54B | 343.07B | 339.64B |
| Total Debt | 520.12B | 993.40B | 198.28B | 179.18B | 166.79B | 191.18B |
| Total Liabilities | 1.91T | 1.78T | 870.27B | 752.02B | 696.86B | 640.64B |
| Stockholders Equity | 336.42B | 320.58B | 170.78B | 166.97B | 157.70B | 147.12B |
Cash Flow | ||||||
| Free Cash Flow | 82.54B | -44.35B | 54.95B | 6.04B | 48.95B | 9.51B |
| Operating Cash Flow | 84.20B | -42.75B | 56.11B | 7.20B | 50.73B | 10.37B |
| Investing Cash Flow | -11.12B | 180.63B | -22.66B | -26.26B | -11.52B | -33.72B |
| Financing Cash Flow | 68.89B | 70.82B | 7.51B | 5.94B | -34.64B | 28.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$308.37B | 8.17 | 6.85% | 2.75% | 91.20% | 30.16% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$446.07B | 7.80 | 11.53% | 2.05% | 48.94% | 36.64% | |
61 Neutral | HK$152.65B | 6.68 | 9.03% | 0.97% | 9.11% | 72.37% | |
59 Neutral | HK$148.32B | 9.05 | 9.55% | 3.83% | 38.36% | 19.98% | |
57 Neutral | HK$183.67B | 9.77 | 8.46% | 2.92% | 28.52% | 6.24% | |
53 Neutral | HK$173.54B | 10.86 | 10.70% | 2.80% | 6.79% | 30.90% |